Data sheet
Data transformation success: Strategies from 3 modern biotech companies
Biotechs are undergoing digital transformations to bring innovations to market faster than ever. From a recent Accenture report, only 37% of companies confirmed having started a pilot of a digital solution in 2019. By 2021, 91% said they were taking at least some action to digitize their labs.
Read case studies on how three leading biotech companies transformed their data practices and as a result, are bringing discoveries to market faster.
In this white paper you’ll learn:
Three universal R&D data limitations among leading biotech companies
Why investing in data was critical for unlocking their digitization efforts
Their tactics for using data and insights to speed up research and reduce R&D costs
View data sheet
Join over 200,000 scientists using Benchling to power their biotech R&D
